Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SonoThera logo — SonoThera is developing ultrasound-mediated nonviral genetic...

SonoThera

SonoThera is developing ultrasound-mediated nonviral genetic therapies.

Founded 2021 United States South San Francisco, United States 54 employees Series A Total: $60.75M Biopharma, Biotechnology

General Information

Company Name SonoThera
Founded Year 2021
Location United States South San Francisco, United States +2
Employees 54
Industries Biopharma, Biotechnology
Funding Stage Series A
Social

Get notified when SonoThera moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SonoThera

SonoThera is a promising player in the Biopharma and Biotechnology industries, founded in 2021 and headquartered in the United States. The company is carving a niche by developing ultrasound-mediated nonviral genetic therapies, a cutting-edge technological approach that sets it apart in the competitive biotech landscape.

The potential impact of SonoThera's technology in personalized medicine and genetic therapy is substantial, offering scalable and potentially safer alternatives to existing viral vector technologies. This innovation has captured significant attention, as reflected in its substantial $60.75M Series A investment dated 01 December 2022.

The investment was spearheaded by an impressive cohort of investors, including Foothill Ventures, Arch Venture Partners, Johnson & Johnson Innovation, Illumina Ventures, among others, showcasing strong market confidence in SonoThera's growth potential and strategic vision.

Taxonomy: ultrasound-mediated therapies, nonviral genetic therapies, genetic medicine, disease treatment innovation, gene therapy, ultrasound technology, therapeutic development, advanced drug delivery, biomedical research, genetic engineering, precision medicine

Services & Products

Development of Ultrasound-Mediated Gene Delivery Technology
Nonviral Genetic Medicine for Targeted Delivery
Research and Development in Genetic Medicine

Target Customers

Patients with Genetic Disorders Pharmaceutical Companies Biotech Research Institutions Healthcare Providers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 11
Investor Investor Investor Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Dec 2022

SonoThera Alternatives & Competitors

View All Alternatives
SonoThera vs
Alcyone Therapeutics Inc.
Alcyone Therapeutics Inc. United States

Alcyone is pioneering next-generation intra-CSF (cerebrospinal fluid) CNS precision gene-based thera...

Series Unknown
37 employees
Biotechnology, Health and Wellness
Compare SonoThera vs Alcyone Therapeutics Inc.
SonoThera vs
Sonio
Sonio United States

Securing pregnancy care

Acquired
106 employees
AI, Health Care
Compare SonoThera vs Sonio
SonoThera vs
Aro Biotherapeutics
Aro Biotherapeutics United States

Series B
51 employees
Biotechnology, Health Care
Compare SonoThera vs Aro Biotherapeutics
Also compare with: SonoThera vs Epicrispr Biotechnologies Epicrispr Biotechnologies View all alternatives

FAQ About SonoThera

SonoThera is developing ultrasound-mediated nonviral genetic therapies.
SonoThera was founded in 2021.
SonoThera is headquartered in South San Francisco, United States.
SonoThera operates in the following industries: Biopharma, Biotechnology.
SonoThera has approximately 54 employees.
SonoThera has completed 1 funding round, raising a total of $60.75M. The latest funding stage is Series A.
SonoThera offers: Development of Ultrasound-Mediated Gene Delivery Technology, Nonviral Genetic Medicine for Targeted Delivery, Research and Development in Genetic Medicine.
Top alternatives and competitors to SonoThera include Alcyone Therapeutics Inc., Sonio, Aro Biotherapeutics, Ligandal, Function. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SonoThera and Alcyone Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SonoThera and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy